TLR4 and cancer: RFX1 downregulates such pro-tumor factors like Toll-like receptor 4 (TLR4) [14], Interleukin 17A (IL17A) [15], interleukin 5 receptor subunit alpha (IL5RA) [16], and helps in cancer mitigation while being anti-inflammatory.